Contraceptive Technology Update – October 1, 2017
October 1, 2017
View Issues
-
Research Finds Many Women Who Receive IUD for Emergency Contraception Continue Use
Sixty-seven percent of women offered long-acting option were using it at one year.
-
Vasectomy Poses Minimal Prostate Cancer Risk
A new systematic review and meta-analysis of three decades of evidence concludes that vasectomies are associated with minimal risk of prostate cancer.
-
Task Force Issues Draft Guidance on Ovarian Screening
The U.S. Preventive Services Task Force has issued a draft recommendation statement on ovarian screening, finding that the potential harms of screening outweigh the benefits.
-
‘Talk. Test. Treat.’ Aimed at Syphilis
There are more reported cases of primary and secondary syphilis in the United States now than there have been in more than 20 years. The Centers for Disease Control and Prevention has issued a call to action to reverse the trend.
-
Increased Focus on Preventing Preeclampsia
Cases of preeclampsia in the United States have increased since 1980 from 2.4% of all pregnancies to 3.8% in 2010. This increase is cause for concern: Preeclampsia accounts for more than $2.18 billion of the healthcare expenditure in the first 12 months after birth.
-
Contraceptive Research: Science Heads to New Frontiers
Funding recently has been awarded to scientists around the globe through the Grand Challenges Explorations program, an initiative funded by the Bill & Melinda Gates Foundation. The program seeks to foster concepts for contraceptive discovery platforms that can contribute to the development of new methods suitable for women and men living in limited resource settings.